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Abstract 
Nutrition of the premature infant has been gaining importance as evidence emerges that early 
support in the critical period plays an important role in the long-term health and 
neurodevelopment of very low birth weight neonates (VLBW).  Traditionally, the components of 
total parenteral nutrition (TPN) were prescribed individually, but more recently, standardized 
formulations have been introduced which may result in cost savings without affecting overall 
nutrition and growth. This systematic literature review comprehensively synthesized the existing 
evidence to date to determine if standardized TPN is an evidenced-based, cost-effective means to 
deliver early nutrition to VLBW infants.  
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Neonates delivered at less than 30 weeks gestation are born at a time of rapid brain and 
body growth. Abrupt cessation of the only source of nutrients for the fetus, the placenta, makes 
the premature infant vulnerable to nutritional deficiencies unless enteral or parenteral nutrition is 
established quickly after delivery (Simmer, Rakshasbhuvankar, & Deshpande, 2013). Compared 
to intrauterine growth profile, infants of very low birth weight (VLBW; less than 1500 grams at 
birth) experience postnatal growth failure that extends even past hospital discharge from the 
neonatal intensive care unit (NICU). The National Institute of Child and Human Development 
Neonatal Research Network indicates that 16% of extremely low birth weight infants are small 
for gestational age at birth, but by 36 weeks corrected age, 89% have growth failure as described 
by weight less than the 10th percentile on the growth chart. Follow up at 18 to 22 months 
corrected age shows that 40% still have weights, length and head circumference less than the 10th 
percentile (Dusick, Poindexter, Ehrenkranz, & Lemons, 2006). Early nutritional support in the 
early critical period plays an important role in the long-term health and neurodevelopment of 
VLBW infants (Ziegler, 2009). Suboptimal growth is common in very low birth weight infants, 
and postnatal growth failure is now recognized as a potentially reversible risk (Dusick et al., 
2006). In very early preterm infants, the risks of early enteral feedings are extremely high and 
feedings are often delayed for several days or weeks and then established slowly (Dusick et al., 
2006). This occurs in order to help prevent necrotizing enterocolitis (NEC), an infection with a 
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high mortality rate in preterm infants. One of the Healthy People 2020 objectives is to reduce the 
rate of neonatal and post-natal deaths with a target of a 10 percent improvement under the MICH 
(Maternal, Infant, and Child Health) 1.4 and 1.5 objectives (Healthy People, 2015). Early, 
adequate parenteral nutrition that can support an infant while enteral feedings are slowly 
established may be a part of reducing the rate of neonatal deaths due to NEC or other diseases. 
Background 
Parenteral nutrition remains the sole means of providing hydration, calories and nutrients 
to VLBW infants in the first few days and weeks after delivery. Many studies have supported the 
use of early TPN in neonates, starting immediately after birth. Ehrenkranz et al. (2006) found 
that greater growth velocity exerts a significant positive effect on neurodevelopmental and 
growth outcomes at 18-22 months corrected age. However, controversy still exists as to the 
optimal composition of TPN. Inadequate or inconsistent nutritional strategies may be one barrier 
to delivering effective parenteral nutrition in the VLBW infants (Morgan et al, 2011). Time, cost, 
and effectiveness of parenteral nutrition all must be considered when establishing guidelines and 
protocols for VLBW infants.  
Clinical Question/Statement 
The objective for this project was to complete a systematic review of the literature to 
determine if standardized TPN solutions provide adequate growth while maintaining metabolic 
stability in the first few weeks after birth to VLBW infants. Is standardized parenteral nutrition a 
safe and effective means to deliver total parenteral nutrition to very low birth weight infants 
during their first days to weeks after birth? Morgan, Herwitker, Badhawi, Hart, Tan, Mayes, 
Newland & Turner (2011) reported that the prescription and formulation of neonatal parenteral 
nutrition is critical to achieving optimal protein and calorie intake but has received little 
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scientific evaluation. The hypothesis is that postnatal growth of premature infants can be 
improved or maintained with a standardized parenteral nutrition.  
Justification of Scholarly Project 
This project was sparked by the idea that each day, a practitioner may spend a 
considerable amount of time individualizing each patient’s TPN, and many of the decisions 
about the additives seemed to be subjective to the ordering practitioner. Was there a better, 
evidence-based approach to provide early and continued standardized TPN to very low birth 
weight infants in a safe and effective manner? Beecroft, Martin, and Puntis (1999) discovered 
that 82% of individualized prescriptions deviated with respect to one or more nutrients from the 
regimen recommended by the computer program. However, only 44% of abnormal biochemical 
results prompted a change in prescription (Beecroft, Martin, & Puntis, 1999). Therefore, most 
deviations were not based on any data from the patient but at the discretion of the provider. 
Standardized TPN formulations are easy and safe to implement to avoid errors and may be cost 
effective (Bolisetty, Osborn, Sinn & Lui, 2014). Standardized TPN formulations became popular 
and are beginning to be implemented in NICUs all over the world since 2010 (Bolisetty, Osborn, 
Sinn & Lui, 2014). The earliest study dates back to 1989 when a pharmacist assigned to a NICU 
at Ohio State University Hospitals simplified the process of ordering and compounding neonatal 
TPN solutions (Bolisetty, Osborn, Sinn & Lui, 2014).  Hartwig and Gardner (1989) discovered 
26 years ago that standardizing TPN solution yielded time and cost savings while decreasing the 
risk of error and enabling neonates to receive adequate calories from a standard solution. Few 
studies have looked at the growth difference between using standardized TPN and even fewer 
have looked at the potential for cost savings. Hospital pharmacies have the potential to save 
thousands of dollars using a standardized formulation (Hartwig and Gardner, 1989). Advanced 
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nurse practitioners, physicians and dieticians who order TPN may save time by using a 
standardized formulation rather than calculating and ordering each individual component.  
Conceptual Framework 
The Barker theory provides an interesting framework for this study. Barker (2012) 
reports that the growth of every human fetus is constrained by the limited capacity of the mother 
and placenta to deliver nutrients to it. In the case of a preterm infant, the capacity for growth is 
limited by nutrition provided intravenously and enterally as the placenta is no longer functioning 
at all. Adverse influences can permanently change body structure and function: a phenomenon 
known as “programming” during development. During development, there are critical periods 
during which a system or organ has to mature. These periods are brief and occur at different 
times for different systems, most occurring before 40 weeks post conception age. Much of 
human development is completed during the first 1000 days after conception (Barker, 2012). 
When an infant is challenged and does not have sufficient resources to perfect every aspect of the 
body, a hierarchy of priorities is developed. Brain growth is at the top of this hierarchy. Brain 
growth is defined as the change in head circumference for the purpose of this study. If the growth 
of a fetus falters because of malnutrition, such as being born prematurely and losing the placenta 
as the source of nutrients, it has the ability to return to its growth trajectory by accelerated 
growth. Growth is defined as the change in weight and length of each infant for the purpose of 
this study. During this time, the fetus or newborn must be supplied with energy to allocate for 
catch-up growth.  
Assumptions 
Very preterm infants have a gut that is too immature to digest milk right after they are 
born to meet their nutritional requirements (Morgan et al., 2011). One assumption is that nearly 
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all preterm infants less than 29 weeks gestation and/or less than1500 grams require parenteral 
nutrition for a period of time that depends on gestational birthweight and other morbidities 
(Morgan et al., 2011). Preterm infants born at less than 29 weeks gestation also have the highest 
incidence of early and late growth failure and long term neurocognitive disability (Morgan et al., 
2011). Effective parenteral nutrition delivery is essential to help avoid major early nutritional 
deficits in these infants (Morgan et al., 2011). 
Hypothesis 
The first hypothesis is that the standardized parenteral nutrition given to neonates in the 
first several day to weeks after birth will provide sufficient nutrients for adequate growth and 
minimize growth failure in the first two weeks. Another working hypothesis is that providing a 
standardized formulation will not negatively alter fluid and electrolyte balances. A third 
hypothesis is there will be a cost savings to hospitals through the use of a standardized solution.  
Definition of Terms 
Several key concepts must be defined for the purpose of this study. Very low birth weight 
infants (VLBW) are born with a weight of less than 1500 grams. Growth is defined as the change 
in grams in weight between two periods in time and the change in centimeters in length and head 
circumference. Standardized TPN is defined as intravenous nutrition that is either commercially 
made or batched by the local pharmacy. The composition of the standardized formulation is 
always the same within the institution.  This standard solution is pre-mixed in the pharmacy or 
bought commercially and often resides in a locked pharmacy cart directly in the NICU until it is 
needed. Individualized or custom TPN is defined as solution designed daily on a computer 
program or hand written by the practitioner for each individual patient. 
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Postnatal growth has been studied extensively in the literature. Fenton & Kim (2013) 
report the ideal growth pattern of preterm infants remains undefined. The current charts provided 
in the literature are growth references, and not growth standards. The closest information about 
growth standards are based on intra-uterine fetal growth, which from 25-30 weeks is 15-20 
grams per kilogram per day, therefore adequate post-natal growth for VLBW infants would be 
10-15 grams per kilogram per day on average (Fenton & Kim, 2013). Metabolic stability can be 
defined as a serum sodium level of between 130mmol/l and 150mmol/l, as well as a potassium 
level less than 6.5mmol/l according to Iacobelli, Bonsante, Vintejoux, & Gouyon (2010). 
Chapter II 
Review of the related literature 
 Very-low-birth-weight (VLBW) infants are born at a time of otherwise rapid 
intrauterine brain and body growth. Rapid establishment of postnatal nutrition is essential to 
provide continued support of growth. Lucas, Morley, & Cole (1998) reported that animal and 
human studies have shown that periods of under nutrition may result in irreversible deficits in 
brain growth. Lucas, Morley, & Cole (1998) also reported the early weeks of life are a critical 
period for neurodevelopment in VLBW infants. A literature review revealed many studies 
support the use of early, aggressive TPN in VLBW infants (Riskin, Shiff, & Shamir, 2006). 
Ibrahim et al. (2004) showed that aggressive intake of amino acids and intralipids can be 
tolerated immediately after birth by VLBW infants. Several studies indicate that sick, premature 
infants tolerate the early administration of amino acids (Riskin, Shiff, & Shamir, 2006). Also, 
early TPN usage significantly increased positive nitrogen balance and caloric intake, without 
increasing the risk of metabolic acidosis in sick premature infants (Adamkin & Radmacher, 
2014). Heimler, Bamberger, & Sasidharan (2010) reported early administration of amino acid 
SCHOLARLY PROJECT III 11 
improved preterm infant weight with less numbers of infants below the tenth percentile in the 
growth curve, although there was a slightly higher incidence of bronchopulmonary dysplasia. 
Summary 
 Although the data supports the use of early TPN in VLBW infants, there may be some 
controversy as to the type of TPN formulation to use during the first few weeks after birth when 
enteral feedings are not yet fully established. Several retrospective, observational studies have 
been conducted around the world to look differences in TPN usage during this time (Embleton & 
Simmer, 204).  A few retrospective studies have shown there is no clinical advantage of 
improved biochemical control with individualized TPN regimes (Yeung, Smyth, Maheshwari & 
Shah, 2003).  Lenclen et al. (2006) found that standardized TPN solutions were superior in terms 
of higher intakes of glucose and amino acids. The main weakness and gap in the literature is the 
small sample sizes of most of the studies and the lack of randomized, controlled trials (RTC) that 
have been conducted.  
Chapter III 
Methodology Design 
 The project design of this study was to complete a thorough systematic literature 
review of all relevant data related to standardized parenteral nutrition in very low birth weight 
infants. Using the Matrix Method (Garrard, 2014) as a guide, a plan to manage a search of the 
literature was established. First, key words were determined in order to provide consistency 
when searching many different databases. The controlled vocabulary terms used in 
MEDLINE/PubMed (also called MeSH) were standardized parenteral nutrition and neonate. 
Second, inclusion criteria for the sample of this literature review were identified and included the 
population of very low birth weight infants (birthweight < 1500 grams) and those who had 
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received a standardized parenteral nutrition for any length of time. The types of studies included 
were randomized controlled trials, retrospective and observation comparative studies. Systematic 
literature reviews, consensus statements, retrospective chart reviews, prospective reviews and 
protocols were all included in the search in order to be completely exhaustive.  Other key words 
that were included were: very low birth weight infant, preterm infant, and standardised. 
Inclusion for outcome measures included growth, biometric measures and/or cost analysis. 
Exclusion criteria included adult and pediatric subjects, and studies involving a standardized 
feeding protocol (including both parenteral and enteral feeding changes). Languages other than 
English that were unable to obtain translation were also excluded. 
Project setting 
The setting of this project included accessing multiple databases, including PubMed, 
ProQuest Allied Health Source, Cochrane, and MEDLINE. In addition to individual databases, 
areas of synthesized research studies were explored. Review articles, meta-analysis, practice 
guidelines and the Cochrane Library were examined as tertiary sources of information for this 
study. The time frame of publications included in this project ranged from 1985 to present.  
Internal Review Board 
The protection of human subjects is documented in each article and reviewed by the 
individual institution’s internal review board (IRB). This systematic literature review study did 
not require a separate IRB approval as each study completed this separately.  
Time frame 
Data collection was completed using the named databases searching for scholarly 
publications on June 20, 2015 and reviewed again on July 10, 2015. Data analysis commenced 
by using the key words standardized parenteral nutrition and neonate or very low birth weight 
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infant in a PubMed search, Cochrane review and ProQuest database.  This search revealed 705 
results. The abstracts were reviewed to determine the relevance and inclusion for this literature 
review. Articles were excluded for pediatric population, including enteral feedings or other 
variables in the protocol, duplicates or using infants with a birthweight >1500 grams. Of the 40 
that passed abstract screen results, nine met the inclusion criteria. Two other articles were cross-
referenced from the reference list in other articles, meeting the inclusion criteria, for a total of 11 
articles reviewed. Data analysis for each article was completed and the evidence graded using the 
Strength of Recommendation Taxonomy (SORT) method. Levels of evidence from one to three 
for individual studies are defined. The SORT scale addresses quality, quantity and consistency of 
evidence of the individual studies or bodies of evidence (Ebell, Siwek, Weiss, Woolf, Susman, 
Ewigman, & Bowman, 2004). An A-level recommendation is based on consistent and good-
quality patient-oriented outcomes that measure changes in morbidity or mortality; a B-level 
recommendation is based on inconsistent or limited-quality patient-orientated evidence; and a C-
level recommendation is based on consensus, usual practice, opinion, disease-oriented evidence 
or case studies (Ebell et al., 2004).  
Limitations of design 
A limitation of this study includes the possibility of not including some articles that are in 
different languages other than English or new articles may be published since this paper was 
written. Another potential limitation is the population studied excluded some neonates that 
require parenteral nutrition as well (>1500 grams), although these infants tend to have a better 
growth trajectory during their NICU stay and better neurodevelopmental outcomes compared 
with VLBW infants (Ehrendranz et al., 2006). These limitations or barriers were addressed by 
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this author receiving email alerts for new or recently published articles on the topic of 
standardized parenteral nutrition and very low birth weight infants.  
Chapter IV 
Results 
Randomized Controlled Study 
Morgan, McGowan, Herwitker, Hart & Turner (2014) conducted the only randomized 
controlled study in this systematic literature review. Two groups of very preterm infants 
(birthweight of <1200 grams) were randomized to a group receiving a standardized, concentrated 
with added macronutrients parenteral nutrition (SCAMP) (n=74) or a control group receiving the 
standardized, neonatal parenteral nutrition formulation in current practice (n=76). All infants in 
both groups received the same clinical standard of care and followed the same protocols for fluid 
management and biochemical monitoring. The primary outcome analysis compared the change 
in head circumference at 28 days between the two groups. Infants were recruited over a 30 
month time frame and randomized right after consent obtained. The article reports a statistically 
significant difference in head circumference between the two groups after 28 days postnatal age, 
reporting a greater change in head growth in the SCAMP group (Morgan et al., 2014). The study 
reports no statistical differences in mortality or major preterm complications were identified. 
There was a trend towards more major cranial ultrasound scan abnormalities in the SCAMP 
group (grade 3/4 intraventricular hemorrhage and periventricular hemorrhage) (n=11 in SCAMP 
group and n= 5 in the control group). The study did report higher protein and calorie intakes over 
the 28 day period in the SCAMP group compared with the control. The SCAMP group was able 
to obtain closer to the recommended 3.5grams per kilogram per day of protein (2.8-3.6 per day) 
compared to the control group (2.4-3.0 per day). Based on the SORT algorithm for determining 
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the level of evidence for an individual study, the Morgan et al. (2014) is a Level of Evidence One 
(See Table 1 for details). 
Review articles 
Four review articles discussed the current trends and practices of parenteral nutrition in 
very low birth weight infants in this systematic literature review. Embleton and Simmer (2014) 
reported in their review, standardized parenteral nutrition has advantages over individualized 
parenteral nutrition including better provision of nutrients, less prescription and administration 
errors, decreased risk of infection and cost savings. The trend of several studies reviewed tends 
to be the idea of providing the amino acid requirements in a relatively small volume, assuring 
that nutrition is not compromised when fluids are restricted in VLBW infants. Adamkin and 
Radmacher (2014) report that standardized TPN formulations are gradually being accepted in 
many neonatal intensive care units in the United States and abroad. Advantages of standardized 
solutions include promotion of safer administration and consistent adherence to guideline-based 
protocols. Standardized TPN increases the timeliness of administration because the pre-mixed 
solutions can be stored in the NICU and started as soon as orders are received (Adamkin & 
Radmacher, 2014). 
 A review by Riskin, Shiff & Shamir (2006) looked at the advantages and disadvantages 
of both individualized and standardized TPN in infants < 1500 grams. The main advantage of 
individualized TPN was it provided the most precise biochemical control because the 
prescription can be changed on a daily basis, reflecting the patient’s most recent laboratory test 
results (Riskin, Shiff & Shamir, 2006). The main advantage for standardized TPN provided 
ready availability as ward stock, enabling early initiation of parenteral nutrition. Standardized 
TPN could reduce pharmacy and practitioner workload and costs, as well as increase safety 
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(Riskin, Shiff & Shamir, 2006). Riskin, Shiff & Shamir (2006) offered the possibility of using a 
combination of standardized TPN and individualized solutions based on the severity of illness of 
the neonate. Riskin, Shiff & Shamir (2006) also suggested gathering data from local experts to 
determine the best possible formulations for standardized TPN. This study was set in Israel, 
where the use of standardized TPN may be very different than in the United States. 
The final article by Kochevar, Guenter, Holcombe, Malone, & Mirtallo (2007) reviewed 
the current literature associated with standardized TPN solutions and provided some 
recommendations. This article was not included in the overall body of evidence for this project 
but worth mentioning in the paper, as the Task Force reviewing the literature did not set a patient 
age criteria. The statement is based on all ages of patients from infants to adults. The American 
Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) is an interdisciplinary organization 
whose members are involved in the provision of clinical nutrition therapies, including parenteral 
and enteral nutrition. A.S.P.E.N. supports clinical practice, research and education. One of the 
interesting recommendations from this paper states than when an organization implements 
standardized TPN formulations, a mechanism should be established to provide or make available 
customized TPN for individuals who have complex requirements (Kochevar et al., 2007). 
Another statement discusses the evidence suggesting advantages in efficiency and economy with 
the use of standardized TPN formulations compared with individualized formulations in select 
populations.  
Retrospective, observational studies 
Five retrospective articles were identified in the cohort discussing standardized TPN. 
Doublet, Vialet, Nicaise, Loundou, Martin & Michel (2013) strictly looked to determine if the 
TPN goals for the neonate were achieved better with a standardized formulation or 
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individualized prescription. The authors compared two one-year periods, before and after a move 
from individualized to standardized formulations. Daily goals for glucose, lipids and amino acids 
are defined in a written policy in the unit where the study was conducted. During the 
standardized TPN period, seven formulations were available, and the practitioner chose the 
standardized formulation best suited for that neonate that day. More than 3500 prescriptions were 
included (n=1474 individualized and n=1740 for the standardized group). The data were 
analyzed using a generalized estimating equation and the group effect was tested via the Wald 
Chi test, with values of p<0.05 considered statistically significant. There was no statistical 
difference in the demographic data of the two groups. The goals were better achieved in the 
standardized group (44%) than in the individualized group (9%), a statistically significant 
difference. The differences between the two groups were significant for each nutrient when 
looked at separately as well on days 7 and 14 for glucose, amino acids and lipids. The 
standardized group achieved goals significantly more often than the individualized group 
(p<0.001, Doublet et al., 2013). This study did not identify any growth or cost variables. 
 Another retrospective study by Smolkin, Diab, Shohat, Jubran, Blazer, Rozen & 
Makhoul (2010) compared two groups of VLBW infants receiving either individualized or 
standardized TPN. The three outcome variables were growth parameters, complications and cost. 
This study was different from the others in the fact the standardized group were infants born 
between January 1, 2000 and December 31, 2001, compared with the matched, individualized 
group born between January 1, 2006 and December 31, 2007. In all the other studies, the 
standardized group was born after the individualized group. During the standardized TPN period, 
five parenteral pre-set formulations were available containing various glucose and amino acid 
concentrations. Smolkin et al. (2010) found the infants in the individualized TPN group achieved 
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full enteral feedings faster than the standardized TPN group, and achieved significantly greater 
weight gain during the first week of life (p=0.036) and over the first month of life (p=0.0004). 
The study reports the infants in the individualized group had significantly higher mean levels of 
glucose (still in the normal range) but lower levels of potassium, phosphorous, albumin and 
direct bilirubin compared with the standardized group. The cost analysis completed by Smolkin 
et al. (2010) reported that individualized TPN costs slightly more than the standardized solution 
(1.5 dollars/infant/day).  
Lenclen, Crauste-Manciet, Narcy, Boukhouna, Greffray, Guerrault, Bordet, & Brossard 
(2006) implemented a change to three standardized parenteral formulations and completed a 
retrospective, observational study to evaluate the relevance of the implemented standardized 
TPN regime. Twenty preterm infants who had received standardized TPN in 2003 were matched 
for twenty infants who had received individualized TPN in 2001. The outcome variables 
compared nutrient intake and biochemical parameters between the two groups. The results of this 
study showed a statistically significant difference in cumulative intakes during the first week of 
life in amino acids, nitrogen, calcium, and phosphate. The standardized group had higher levels 
of all four nutrients listed previously. Lenclen et al. (20060) identified some differences in 
biochemical parameters between the two groups as well. Blood creatinine was less in the 
standardized group on day three. The phosphorous level was less in the individualized group on 
day three but by day eight, the only difference was in the total carbon dioxide level (16.1 mmol/l 
versus 19.4 mmol/l, p=0.016, which was less in the individualized group. The results show a 
standardized solution provides better nutrient supplies, especially with respect to amino acids. 
Although this study did not report any data on growth, the higher amino acid intake is in 
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compliance with current practice to optimize early protein supplies in the VLBW infants 
(Ziegler, Thureen, & Carlson, 2002). 
A retrospective, observational study also evaluated the difference in nutrient intakes and 
biochemical responses in infants who received standardized versus individualized TPN regimes. 
Yeung, Smyth, Maheshwari & Shah (2003) studied 31 infants who had received individualized 
TPN compared with 27 infants who received standardized TPN formulations (two different 
solutions available to choose from) that were commercially batch produced. Data sets from the 
two groups of infants, between day two and day seven of age, were compared. There was no 
statistically significant difference between the standardized TPN group and the individualized 
TPN group in terms of daily glucose intakes. Infants in the standardized group received 
significantly more protein (p<0.02) each day and also received 25% more calcium and phosphate 
from day 3 that the individualized group (Yeung et al., 2003). This was a short term study of two 
methods of providing TPN during the first seven days of life, which makes this study more 
difficult to infer that standardized TPN should be used longer term for VLBW infants. The 
Yeung et al. (2003) study also has smaller sample sizes than other, comparative studies, making 
the results more difficult to interpret. (See Table 1 for breakdown of level of evidence for each 
individual study) 
The final retrospective study by Morgan, Badhaw, Grime & Herwitker (2009) collected 
data prior and after the implementation of three different standardized configurations of TPN. 
The selection of choices one, two or three was based on clinical assessment and electrolyte 
measurements taken daily. The total number of infants in the study period was 118, with 59 in 
the individualized group and 38 in the standardized group. The data from this study show an 
increased effectiveness of the standardized TPN deliver, reflected in improved 14-day protein 
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intake when compared to individualized TPN group. Morgan et al. (2009) also showed an annual 
cost savings following the introduction of standardized TPN with a reduction of 38% compared 
with the previous individualized group.  
Prospective studies 
One prospective trial was identified in the literature. A prospective study by Iacobelli, 
Bonsante, Vintejoux & Gouyon (2010) compared fluid and electrolyte balance in preterm infants 
receiving either individualized or standardized TPN solutions in the first week of life. This study 
was conducted over two consecutive periods June 1 to October 31, 2006 (individualized group) 
and from November 1 to July 31, 2007 (standardized group). Eight different standardized 
solutions were used for day one to day seven of life. Icaobelli et al. (2010) found that 
standardized parenteral nutrition was associated with significantly reduced weight loss compared 
to the individualized nutrition. The study also concluded that there was no significant differences 
in water and sodium balance between the two groups. The risk of nonoliguric hyperkalemia was 
higher in the individualized TPN group compared with the standardized group. The design of 
this study may be a limitation as the groups were observed prospectively, not randomized, and 
the two groups were not completely homogeneous. Icaobelli et al.  (2010) used a different 
standardized formulation every day, which differed by content of glucose, lipids and amino 
acids. Electrolyte additives also changed slightly each day for each bag (for example, potassium 
and phosphorous added on day 3). However, the assessment of early and increased amount of 
protein (as seen in the standardized TPN) intake in the first week of life limiting postnatal weight 
loss in VLBW infants confirms results already obtained by other investigators.  
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Pilot Study 
A pilot study consisting of 30 admitted infants that could be followed for 30 days 
receiving a standardized formulation of nutrients was completed by Devlieger, Pourcq, Casneuf, 
Vanhole, de Zegher, Jaeken & Eggermont (1993). The NICU where the study occurred designed 
four amino acid-dextrose mixtures with a fixed nutrient load in four dilutions to administer to 
small sample of patients as a pilot. The solutions delivered a fixed amount of nutrients diluted 
with water corresponding to a fluid load of 90, 110, 130, or 170 milliliters per kilogram of total 
fluid per day.  The goal of total parenteral nutrition in VLBW infants is to match as closely as 
possible the intrauterine growth rate and qualitative accretion rate. The Devlieger et al. (1993) 
study reported a weight gain corresponding to the intrauterine weight accretion after the initial 7-
10 days of weight loss or stabilization. This study reported numerous advantages of a 
standardized solution including the time spent on individual prescription and preparation of the 
formula as well as errors in prescription and preparation are minimized. Devlieger et al. (1993) 
also looked at the safety of the preparation and storage of the standardized TPN solution. 
Samples of the TPN bags were sent for chemical analysis and bacterial counts. The study did not 
reveal how many bags, if any, were found to be contaminated. Devlieger et al. (1993) reported 
the solutions were prepared under aseptic conditions using a Millipore filter, under laminar air 
flow and sealed into 500 ml plastic bags.  Overall, this study and the standardized system that 
was used turned out to have advantages in this specific NICU.  
Analysis of Evidence 
First, the study mean, range and characteristics are analyzed. All the subjects for the 
studies are very low birth weight infants. The mean for those studies that included a sample size 
(7 out of 11) in the systematic literature review was 89, with the range from 40 to 150. The 
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review articles were excluded in this data analysis as several of the studies cited were duplicates, 
and this would have artificially inflated the systematic review sample size. The small sample 
sizes may be due partly to the specific patient population reviewed in this literature. 
Each individual article identified in this study was evaluated using the SORT taxonomy 
to grade the level of evidence provided in each paper. The first part of the algorithm for 
determining level of evidence is deciding if the key outcome of the study is based on patient-
oriented evidence (improvement in morbidity, mortality, quality of life or cost). All eleven 
articles in this study passed this first criteria. The next step in the algorithm is to ascertain if the 
study is based on opinion, a guideline, usual practice, clinical experience or a case study (Ebell et 
al., 2004). None of the articles reviewed in this literature search were based on opinion, usual 
practice, experience or a case study, moving them up to a level one or two. The final step in 
establishing the level of evidence is to review the type of study (randomized controlled trial, 
prospective, retrospective study, etc.) and determine if each study meets the guidelines listed in 
Ebell et al. (2004) for level of evidence 1 or 2. See Table 1 for a detailed breakdown of each 
study and the level of evidence presented according to the SORT taxonomy.  
Table 3 presents data copulated from four different studies in this systematic review 
looking at safety and biochemical responses between groups receiving either standardized or 
individualized TPN. Several variables were lower in the standardized TPN solution group. These 
variables include a lower base deficit, insulin levels and incidence of hyperkalemia. Variables 
that were similar between the two groups include serum creatinine concentration and creatinine 
clearance. Only the mean serum glucose levels were higher in the control (individualized) group.  
Growth and effectiveness were evaluated in Table 4. One study found better growth in 
the individualized group. Three other studies presented data supporting improved growth with a 
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standardized group. The other study that described the effectiveness or amount of time the 
parenteral nutrition goals were met favored the standardized TPN group at 44% versus the 
individualized group at 9.4%.  
Chapter V 
Discussion 
The strength of recommendation for clinical practice change is based on the body of 
evidence and typically involves more than one study (Ebell, Siwek, Weiss, Woolf, Susman, 
Ewigman, & Bowman, 2004). To determine the strength of recommendation, one must take into 
account the level of evidence of individual studies, the number, consistency and coherence of the 
evidence as a whole (Ebell et al., 2004).  A systematic review is a critical assessment of existing 
evidence that addresses a focused clinical question. The clinical question is standardized TPN 
safe and effective in providing nutritional support to VLBW infants is addressed in this project. 
The strength of recommendation that using standardized TPN solutions for VLBW infants is safe 
and effective can be classified as B level, a recommendation based on inconsistent or limited-
quality patient-oriented evidence. The justification for the level B is that the individual studies 
were strong and well conducted, but the number and type of standardized TPN solutions differed 
for each study. There was little to no consistency in how many standardized solutions each study 
used. The exact composition of the TPN bags also differed in the studies, or weren’t identified in 
many of the studies. 
First and foremost, the safety of a new clinical standard must be assured. Several of the 
studies in this systematic review reported no differences in biochemical responses (measuring 
electrolyte and kidney function) between the current standard or individualized usage TPN and 
new standardized TPN bags. In fact, Iacobelli et al. (2010) found nonoliguric hyperkalemia was 
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significantly more frequent in the individualized TPN compared to standardized bags of TPN. 
Iacobelli et al. (2010) also reported percentage of weight loss was significantly higher in 
individualized TPN than in the standardized TPN group, without differences in urine output and 
glomerular renal function. Yeung et al. (2003) reported a higher base deficit on day 6 for infants 
receiving individualized TPN, the only significant biochemical difference between the groups.  
Second, the efficacy of the clinical standard should be assessed. Will VLBW infants 
grow as well or better given standardized TPN than the current practice? This was difficult to 
measure in this systematic literature review. Several articles used different numbers of 
standardized TPN solutions, with the range from two to seven (see Table 2). The nutrient intake 
was also different in several studies. The amino acid concentration ranged from 1.5-3 grams per 
100 milliliters in order to achieve a goal of 3-4 grams per kilogram per day of protein (amino 
acids). The glucose concentrations also varied between standardized TPN bags (2.5- 11%) 
(Smolkin et al., 2010). Several studies looked at the amino acid intake during the first few weeks, 
but did not report the actual growth measurements (Lenclen et al., 2006). Morgan et al. (2014) 
did measure head growth, finding the group receiving more protein and energy had a higher rate 
of head growth at day of life 28.   
A third consideration of a new clinical standard is the cost. Four of the eleven articles 
reviewed in depth for this systematic literature review mentioned cost as a factor for standardized 
TPN. All four showed a benefit of up to 38% lower cost of the standardized TPN versus 
individualized TPN. In addition to a cost savings, several studies mentioned standardization 
reduces the chances of potential errors and is thus safer (Riskin et al., 2006). Standardization also 
has the potential to reduce the time a practitioner spends on calculating and ordering TPN 
(Riskin et al., 2006). 
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Limitations of studies 
Several limitations can be identified in the included studies and in the systematic 
literature review. As stated previously, most of the studies used different numbers of 
standardized TPN solutions, ranging from two to seven. Also, most of the studies were 
retrospective reviews, with the change to a standardized solution occurring after the use of 
individualized solutions. Improvement in neonatal outcomes continues to improve over time, as 
many changes can occur over the time frame that would lead to better growth. One example of 
this is the push for more skin-to-skin care in NICUs over the last 5-10 years has been shown to 
help growth as well (Khanam, Khan, Sharma, Chawla, & Munki, 2014). Another limitation of 
this literature review is that it only included very low birth weight infants, so generalizability to 
all NICU infants is not appropriate.  
As with many other studies and literature reviews, the more the data are reviewed, the 
more readers identify that future studies are needed to clarify results. More randomized, 
controlled trials between standardized TPN solutions could identify which concentrations benefit 
growth and nutrition the best.  
Budget 
The budget for this project was mainly based on the author’s time involved in 
researching, writing and then presenting the information. The assistance of the librarian liaison to 
the College of Nursing at the University was a wonderful help and paid in kind. Creating a poster 
about the project and speaking at conferences may account for a nominal cost. 
Dissemination Plan 
Publication is one of the most common forms of project dissemination. The first choice 
of publication for this paper is the American Journal of Clinical Nutrition. With an impact factor 
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of 6.9 for this journal, the article discussing standardized parenteral nutrition in the very low 
birth weight infant has the potential of reaching more people that may be in the clinical decision-
making role, and thus utilize the information. The very low birth weight neonatal population is a 
small, specialized population of health care. Presenting the information gathered from the 
systematic literature review is another way to disseminate the information. Journal club meetings 
or state and national conferences may be a format to present this study. Speaking first-hand gives 
direct access to the researcher and offers an opportunity for questions and comments by other 
health care professionals.  
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Appendix A 











699 citations identified 
11 articles included in systematic 
literature review:  
1 RTC 
3 review articles 
5 retrospective, observational 
1 prospective trial 
1 pilot study 
31 articles excluded: 
Included patients >1500 grams:  
13 
“Standardized” plan included 
enteral feedings: 9 
Discussed early amino acid 
(“starter TPN”): 2 
Discussed electronic/computer-
assisted (not defined as 
standardized): 3 
Written before 1985: 1 
Not in English: 3 
40 Passed abstract screening 
Abstracts excluded: 659 
Cross-referenced: 2 
Duplicates: 6 
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Appendix C 
Table 2. Number of solutions used and cost analysis 
Article Number of standardized TPN 
solutions in the study 
Cost savings presented in study 
Adamkin et al. (2014) N/A N/A 
Embleton et al. (2014) N/A N/A 
Morgan et al. (2014) 3 N/A 
Doublet et al. (2013) 7 N/A 
Smolkin et al. (2010) 5 Individualized TPN cost $1.50 
more per infant per day 
Iacobelli et al. (2010) N/A N/A 
Morgan et al. (2009) 3 38% lower cost in standardized 
TPN group 
Riskin et al. (2006) N/A N/A 
Lenclen et al. (2006) 3 N/A 
Yeung et al. (2003) 2 30% lower cost in standardized 
TPN group 
Devlieger et al. (1993) 4 Stated standardized TPN group 
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Appendix D 





n= control group p-value 
Base deficit- days 2, 
7 
27 31 p= 0.04 (0.01-2.27) 
lower in STD 
Insulin infusion first 
week 
20 20 p<0.06 (lower in 
STD) 
Mean urine output 
days 1-7 








40 67 P<0.05 (higher in 
STD only day 6) 
Serum creatinine 
concentration 
40 67 Similar in 2 groups 
Creatinine clearance 40 67 Similar in 2 groups 
Mean serum glucose 
levels 
















   
Variable n = Standardized 
group(STD) 
n= Control group p value 
% of rx fulfilling PN 
goals 
1740 1474 STD- 44% 
IND- 9.4% 
Weight gain 1 week 70 70 p= 0.036 (control) 
Weight gain 1 month 70 70 p=0.0004 (control) 
DC weight 70 70 p=0.012 (control) 
DC Head Circum 70 70 p=0.006 (control) 
Intake AA (first week) 20 20 p=0.003 (STD) 
Intake Ca (first week) 20 20 p=0.0001(control) 
Intake Phosphate 20 20 p=0.0001 (STD) 
Protein intake 14 days 59 38 p<0.001 (STD) 
Protein intake 28 days 74 76 11% more (STD) 
Difference in HC 28 day 74 76 p>0.001 (95%CI) (STD) 
